We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
Cap. Flow
-$1.18B
Cap. Flow %
-6.05%
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78

Sector Composition

Rank Sector Weight
1 Technology 36.16%
2 Healthcare 20.31%
3 Consumer Discretionary 12.43%
4 Industrials 10.17%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
76
Insulet
PODD
$11.6B
$76.3M 0.39%
264,567
-112,335
-30% -$34.1M
ANET icon
77
Arista Networks
ANET
$211B
$76M 0.39%
1,875,068
-273,184
-13% -$10.6M
INTU icon
78
Intuit
INTU
$83.7B
$75.7M 0.39%
165,239
-428,047
-72% -$187M
ATRC icon
79
AtriCure
ATRC
$1.85B
$72.3M 0.37%
1,465,378
-45,926
-3% -$2.12M
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$123B
$71.3M 0.36%
202,677
+32,509
+19% +$11M
CHX
81
DELISTED
ChampionX
CHX
$68.2M 0.35%
2,198,232
-287,143
-12% -$7.91M
CFLT
82
DELISTED
Confluent
CFLT
$68M 0.35%
+1,925,103
New +$53.9M
LLY icon
83
Eli Lilly
LLY
$1.07T
$67.5M 0.34%
143,965
+55,441
+63% +$23.3M
CWAN
84
DELISTED
Clearwater Analytics
CWAN
$66.9M 0.34%
4,214,449
-37,453
-0.9% -$591K
TRNS icon
85
Transcat
TRNS
$785M
$65.7M 0.34%
770,101
+42,876
+6% +$3.65M
MGM icon
86
MGM Resorts International
MGM
$11.8B
$65.4M 0.33%
1,488,339
-548,136
-27% -$23.4M
CLB icon
87
Core Laboratories
CLB
$527M
$63.4M 0.32%
2,728,746
-853,758
-24% -$19.3M
BRKR icon
88
Bruker
BRKR
$9.25B
$63.2M 0.32%
855,604
-169,170
-17% -$12.9M
STEP icon
89
StepStone Group
STEP
$3.63B
$62.9M 0.32%
2,534,383
+40,795
+2% +$937K
FSLR icon
90
First Solar
FSLR
$21.7B
$62M 0.32%
326,192
-139,297
-30% -$27.6M
HLNE icon
91
Hamilton Lane
HLNE
$3.8B
$61.9M 0.32%
773,688
-216,054
-22% -$15.5M
QDEL icon
92
QuidelOrtho
QDEL
$1.14B
$60.9M 0.31%
734,897
-119,946
-14% -$10.5M
AGYS icon
93
Agilysys
AGYS
$2.93B
$59.9M 0.31%
872,536
-43,966
-5% -$3.31M
CABA icon
94
Cabaletta Bio
CABA
$435M
$59M 0.3%
4,572,886
+557,576
+14% +$6.05M
ETN icon
95
Eaton
ETN
$152B
$57.7M 0.29%
286,943
-332,538
-54% -$58.5M
LYV icon
96
Live Nation Entertainment
LYV
$41.8B
$57.7M 0.29%
633,234
-467,069
-42% -$36.5M
MDB icon
97
MongoDB
MDB
$24.9B
$57.1M 0.29%
138,970
+119,656
+620% +$34.9M
LNG icon
98
Cheniere Energy
LNG
$54.4B
$55.4M 0.28%
363,852
-51,555
-12% -$7.63M
BL icon
99
BlackLine
BL
$1.79B
$54.4M 0.28%
1,011,255
-145,150
-13% -$8.06M
ACAD icon
100
Acadia Pharmaceuticals
ACAD
$4.32B
$53.7M 0.27%
2,241,065
+515,439
+30% +$11.5M

Similar funds

Fred Alger Management's Q2 2023 Portfolio in Review

As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.

  • Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
  • Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
  • Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
  • Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
  • Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
  • Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
  • Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.

Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.